SHANGHAI LUMOSA THERAPEUTICS CO., LTD.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SHANGHAI LUMOSA THERAPEUTICS CO., LTD..The latest application filed is for "pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester".

Company Profile

12.12.12

SHANGHAI LUMOSA THERAPEUTICS CO., LTD. - Shanghai CN
SHANGHAI LUMOSA THERAPEUTICS CO., LTD. -
Shanghai Lumosa Therapeutics, Co., Ltd. - Shanghai Pilot Free Trade Zone CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Formulations For Sustained Release Of Sebacoyl Dinalbuphine Ester App 20220071987 - LI; Chan-Jung ; et al.	2022-03-10
Single-domain Antibody-cytosine Deaminase Fusion Proteins App 20220056149 - CHEN; Pei-Jiun ; et al.	2022-02-24
Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester Grant 11,241,424 - Li , et al. February 8, 2	2022-02-08
Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester Grant 11,234,974 - Li , et al. February 1, 2	2022-02-01
Compounds Having Triple Activities Of Thrombolysis, Antithrombotic And Radical Scavenging App 20210355163 - PENG; Shi-Qi ; et al.	2021-11-18
Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting Grant 10,806,798 - Peng , et al. October 20, 2	2020-10-20
Pharmaceutical Formulations For Sustained Release Of Sebacoyl Dinalbuphine Ester App 20200179372A1 -	2020-06-11
Pharmaceutical Formulations For Sustained Release Of Sebacoyl Dinalbuphine Ester App 20200179373A1 -	2020-06-11
Compounds Having Triple Activities Of Thrombolysis, Antithrombotic And Radical Scavenging App 20200055895 - PENG; Shi-Qi ; et al.	2020-02-20
Pharmaceutical Formulations For Sustained Release Of Sebacoyl Dinalbuphine Ester App 20200030318 - LI; Chan-Jung ; et al.	2020-01-30
Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging Grant 10,351,594 - Peng , et al. July 16, 2	2019-07-16
Single-domain Antibody-cytosine Deaminase Fusion Proteins App 20190202931 - CHEN; Pei-Jiun ; et al.	2019-07-04
Pharmaceutical Formulations For Sustained Release Of Sebacoyl Dinalbuphine Ester App 20190160053 - LI; Chan-Jung ; et al.	2019-05-30
Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester Grant 10,183,018 - Li , et al. Ja	2019-01-22
Compound With Effects Of Thrombolysis, Free Radical Scavenging And Thrombus-targeting App 20180264126 - PENG; Shiqi ; et al.	2018-09-20
Process For Preparing Compounds Having Triple Activities Of Thrombolysis, Antithrombotic And Radical Scavenging App 20180134748 - PENG; Shi-Qi ; et al.	2018-05-17
Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof Grant 9,890,193 - Peng , et al. February 13, 2	2018-02-13
Pharmaceutical Formulations For Sustained Release Of Sebacoyl Dinalbuphine Ester App 20160346275 - LI; Chan-Jung ; et al.	2016-12-01
New Compounds Having Triple Activities Of Thrombolysis, Antithrombotic And Radical Scavenging, And Synthesis, Nano-structure And Use Thereof App 20160083423 - PENG; Shi-Qi ; et al.	2016-03-24
Novel Compound With Effects Of Thrombolysis, Free Radical Scavenging And Thrombus-targeting As Well As Preparation Method And Use Thereof App 20150290339 - Peng; Shiqi ; et al.	2015-10-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.